We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Bans Drugs From India’s Polydrug Labs, Citing GMP Issues
FDA Bans Drugs From India’s Polydrug Labs, Citing GMP Issues
The FDA has banned imports of drugs made at Mumbai-India based Polydrug Laboratories, marking the latest development in ongoing issues involving Indian manufacturers.